RETINA-AI Health, Inc. declares positive pivotal study results for the RETINA-AI Galaxy™ autonomous Diabetic Retinopathy screening device
On September 20, 2021, RETINA-AI Health, Inc. announced optimistic results from the pivotal study of the RETINA-AI Galaxy™, a multi-device compatible autonomous diabetic retinopathy screening device planned for use in primary care settings. The company has also filed for the US Food and Drug Administration (FDA) for clearance.
These results were presented at the Society for Imaging Informatics in Medicine (SiiM)'s Conference on Machine Intelligence in Medical Imaging (CMIMI21).
The company conducted a mu...